Ranch Capital Advisors’s Zomedica Corp. ZOM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-10,000
Closed -$1.2K 146
2024
Q4
$1.2K Hold
10,000
﹤0.01% 141
2024
Q3
$1.37K Hold
10,000
﹤0.01% 147
2024
Q2
$1.46K Hold
10,000
﹤0.01% 153
2024
Q1
$1.46K Hold
10,000
﹤0.01% 154
2023
Q4
$2K Hold
10,000
﹤0.01% 146
2023
Q3
$1.67K Hold
10,000
﹤0.01% 142
2023
Q2
$2K Hold
10,000
﹤0.01% 144
2023
Q1
$2.12K Hold
10,000
﹤0.01% 146
2022
Q4
$1.63K Hold
10,000
﹤0.01% 146
2022
Q3
$2K Hold
10,000
﹤0.01% 145
2022
Q2
$2K Hold
10,000
﹤0.01% 144
2022
Q1
$3K Hold
10,000
﹤0.01% 160
2021
Q4
$3K Hold
10,000
﹤0.01% 156
2021
Q3
$5K Hold
10,000
﹤0.01% 557
2021
Q2
$8K Hold
10,000
﹤0.01% 690
2021
Q1
$15K Hold
10,000
0.01% 545
2020
Q4
$2K Buy
+10,000
New +$1.27K ﹤0.01% 822
2020
Q3
Sell
-10,000
Closed -$1K 964
2020
Q2
$1K Buy
+10,000
New +$1.91K ﹤0.01% 893

Other funds holding ZOM

Ranch Capital Advisors's ZOM Position: Q1 2025 in Review

Ranch Capital Advisors sold out of Zomedica Corp. (ZOM) in Q1 2025, closing a stake of 10,000 shares — an estimated $1.2K sold.

Ranch Capital Advisors first reported a position in ZOM in Q2 2020 and held it in 18 quarters. The position peaked at $15K in Q1 2021. 23 funds tracked by Wall St. Rank hold ZOM as of Q1 2025.

  • Ranch Capital Advisors reported no remaining Zomedica Corp. position as of Q1 2025 after selling out during the quarter.
  • Ranch Capital Advisors sold 10,000 Zomedica Corp. shares in Q1 2025, an estimated $1.2K.
  • Ranch Capital Advisors first reported a position in Zomedica Corp. in Q2 2020 and held it in 18 quarters.
  • Ranch Capital Advisors's Zomedica Corp. position peaked at $15K in Q1 2021.
  • 23 funds tracked by Wall St. Rank held Zomedica Corp. as of Q1 2025.

Based on Ranch Capital Advisors's 13F filing for Q1 2025, filed 9 May 2025.